Sei Investments CO Denali Therapeutics Inc. Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

A detailed history of Sei Investments CO transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Sei Investments CO holds 26,276 shares of DNLI stock, worth $635,353. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,276

Previous 22,670 15.91%

Holding current value

$635,353

Previous $526,000 45.44%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$20.96 - $31.05 $75,581 - $111,966	3,606 Added 15.91%	26,276 $765,000
Q2 2024 Aug 13, 2024	BUY	$14.96 - $23.22 $158,546 - $246,085	10,598 Added 87.79%	22,670 $526,000
Q1 2024 May 07, 2024	BUY	$15.83 - $23.35 $3,340 - $4,926	211 Added 1.78%	12,072 $247,000
Q4 2023 Feb 14, 2024	SELL	$16.2 - $23.18 $6,463 - $9,248	-399 Reduced 3.25%	11,861 $254,000
Q3 2023 Nov 14, 2023	SELL	$20.63 - $30.17 $87,904 - $128,554	-4,261 Reduced 25.79%	12,260 $252,000
Q2 2023 Aug 11, 2023	BUY	$23.37 - $32.96 $3,575 - $5,042	153 Added 0.93%	16,521 $487,000
Q1 2023 May 12, 2023	BUY	$21.91 - $32.67 $80,343 - $119,800	3,667 Added 28.87%	16,368 $377,000
Q4 2022 Feb 10, 2023	SELL	$26.28 - $33.92 $87,170 - $112,512	-3,317 Reduced 20.71%	12,701 $353,000
Q3 2022 Nov 14, 2022	BUY	$25.97 - $38.53 $146,990 - $218,079	5,660 Added 54.64%	16,018 $492,000
Q2 2022 Aug 15, 2022	SELL	$20.88 - $35.19 $3,340 - $5,630	-160 Reduced 1.52%	10,358 $305,000
Q1 2022 May 13, 2022	SELL	$29.0 - $47.27 $24,186 - $39,423	-834 Reduced 7.35%	10,518 $328,000
Q4 2021 Feb 14, 2022	SELL	$42.59 - $55.02 $18,441 - $23,823	-433 Reduced 3.67%	11,352 $498,000
Q3 2021 Nov 12, 2021	BUY	$48.48 - $78.23 $153,875 - $248,302	3,174 Added 36.86%	11,785 $588,000
Q2 2021 Aug 06, 2021	SELL	$50.3 - $78.44 $559,285 - $872,174	-11,119 Reduced 56.36%	8,611 $675,000
Q1 2021 May 12, 2021	BUY	$53.8 - $81.53 $100,283 - $151,971	1,864 Added 10.43%	19,730 $1.43 Million
Q4 2020 Feb 08, 2021	SELL	$36.89 - $93.56 $18,076 - $45,844	-490 Reduced 2.67%	17,866 $1.5 Million
Q3 2020 Nov 06, 2020	BUY	$23.13 - $38.84 $424,574 - $712,947	18,356 New	18,356 $658,000

Others Institutions Holding DNLI

# of Institutions

228

Shares Held

120M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.24B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Denali Therapeutics Inc. Transaction History